Protease-activated receptors and prostaglandins in inflammatory lung disease.
about
Developments in the field of allergy mechanisms in 2015 through the eyes of Clinical & Experimental Allergy.A highly potent agonist to protease-activated receptor-2 reveals apical activation of the airway epithelium resulting in Ca2+-regulated ion conductanceInhibition of airway epithelial-to-mesenchymal transition and fibrosis by kaempferol in endotoxin-induced epithelial cells and ovalbumin-sensitized mice.Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain stateThe clinical assessment of protease-activated receptor-2 expression in inflammatory cells from peripheral blood and bronchoalveolar lavage fluid in idiopathic pulmonary fibrosisRegulation of smooth muscle contraction by the epithelium: role of prostaglandins.Role of PGE2 in asthma and nonasthmatic eosinophilic bronchitis.Adhesion GPCR Function in Pulmonary Development and Disease.Identification and expression patterns of members of the protease-activated receptor (PAR) gene family during zebrafish development.Factor XI deficiency enhances the pulmonary allergic response to house dust mite in mice independent of factor XII.Protease-activated receptor-1: key player in the sepsis coagulation-inflammation crosstalk.Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study.Puerarin attenuates ovalbumin-induced lung inflammation and hemostatic unbalance in rat asthma model.Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouseMediators and receptors in the resolution of inflammation: drug targeting opportunities.Protease-activated receptor 2 activates airway apical membrane chloride permeability and increases ciliary beating.A bronchoprotective role for in a murine model of lipopolysaccharide-induced airways inflammation
P2860
Q30275827-58050D24-0170-4FF8-9137-CDC6712A92B5Q34353956-02B2901A-9D51-4F60-ADF7-FD244EB7B2A9Q34394894-1A328D87-D063-4DDE-9D97-4985F90895FAQ36108394-BCFF12AB-F57C-47BA-BA66-C44ED0E85FF3Q36962467-B4023ACE-6CB0-4C47-AE85-CA92ABF4A27EQ37888990-757232D3-4F0B-4008-A38C-E953849BC147Q38005107-1EA984E3-EFB3-4D51-8307-8E8DC42E14FBQ38731913-66511FC5-7051-4B02-B0E1-7CAF02685321Q40405585-EEB0E76A-0ADE-4EB9-9C0E-FED123DE1330Q40425828-972CB587-9D4B-4B09-8D11-C3A045D6C549Q40703168-C51A1122-624F-4880-8673-EB4A569903F2Q41525556-B88C30F0-4C61-4180-AC27-7CB7E6E1FA32Q41850407-214AB9C3-107D-4621-B936-90BE23A79D56Q41955516-4FC37F4E-7666-4DEF-AC22-DACB37DE1C3DQ42681904-68088BBC-4497-4509-BD7C-27CD5B1B0F6AQ47713687-CB864D49-E8F8-435B-A484-16D4AD533FADQ57298374-CB3DF79B-B6CF-4A0A-AC47-8DC2EE6E367C
P2860
Protease-activated receptors and prostaglandins in inflammatory lung disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protease-activated receptors and prostaglandins in inflammatory lung disease.
@en
Protease-activated receptors and prostaglandins in inflammatory lung disease.
@nl
type
label
Protease-activated receptors and prostaglandins in inflammatory lung disease.
@en
Protease-activated receptors and prostaglandins in inflammatory lung disease.
@nl
prefLabel
Protease-activated receptors and prostaglandins in inflammatory lung disease.
@en
Protease-activated receptors and prostaglandins in inflammatory lung disease.
@nl
P2860
P1476
Protease-activated receptors and prostaglandins in inflammatory lung disease
@en
P2093
Terence Peters
P2860
P304
P356
10.1111/J.1476-5381.2009.00449.X
P407
P577
2009-10-01T00:00:00Z